Cargando…
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
The objective of this study is to identify post SARS-CoV-2 vaccine BNT162b2 (BioNTech & Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano Heredia Hospital, Lima, Peru. A descriptive observational study was designed in patients with SLE at the Immuno-Rheumat...
Autores principales: | Zavala-Flores, Ernesto, Salcedo-Matienzo, Jannin, Quiroz-Alva, Ana, Berrocal-Kasay, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592807/ https://www.ncbi.nlm.nih.gov/pubmed/34782941 http://dx.doi.org/10.1007/s10067-021-05980-5 |
Ejemplares similares
-
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus
por: Mok, Chi Chiu, et al.
Publicado: (2022) -
Flares in patients with systemic lupus erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2020) -
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
por: Barbhaiya, Medha, et al.
Publicado: (2021) -
Visceral Leishmaniasis or Systemic Lupus Erythematosus Flare?
por: Garg, Sunny, et al.
Publicado: (2012) -
Infection in systemic lupus erythematosus, similarities, and differences with lupus flare
por: Jung, Ju-Yang, et al.
Publicado: (2017)